Clinical Trial

Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients

Recruiting
View on ClinicalTrials.gov →
Summary
This project aims to assess the expression levels of novel molecular markers identified through screening in clinical samples of malignant pleural effusion, to evaluate the feasibility and clinical utility of these markers as potential diagnostic genes for lung adenocarcinoma.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-01.
Status change: Not Yet Recruiting → Recruiting 2026-03-04
Trial Details
NCT Number NCT07012759
Lead Sponsor Fu Jen Catholic University
Conditions Biomarkers, Lung Adenocarcinoma, Pleural Effusion
Enrollment 100 participants
Start Date 2025-06-10
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-05